Records containing: Prader-Willi Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-10-19A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi Syndrome
-
CLINICAL_TRIALS study record update · 2023-09-21A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2023-09-06GROWing Up With Rare GENEtic Syndromes ….When Children With Complex Genetic Syndromes Reach Adult Age
-
CLINICAL_TRIALS study record update · 2023-09-06Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2023-08-24Circulating Levels of Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and / or Overweight, and / or Obesity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-08-23Communication in Prader-Willi Syndrome: Study of Emotional Control Related to Behavioral Disorders, Their Daily Repercussions and Examination of an Innovative Therapy: Transcutaneous Electrical Nerve Stimulation of the Vagus Nerve - PRACOM1
-
CLINICAL_TRIALS study record update · 2023-08-09A Phase 1, Single Center, Open Label, Single Dose, Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2023-08-01A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2023-07-27A Phase 2, Randomized, Double-Blind, Placebo-controlled Pilot Study to Assess the Effects of RM-493, a Melanocortin 4 Receptor (MC4R) Agonist, in Obese Subjects With Prader-Willi Syndrome (PWS) on Safety, Weight Reduction, and Food-Related Behaviors
-
CLINICAL_TRIALS study record update · 2023-06-22A Multicenter, Open-Label Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2023-06-01Effect of Intranasal Oxytocin on Dysphagia Related to Oropharyngo-oesophageal Dysmotility in Children and Adolescents With Prader-Willi Syndrome: a Phase 2B Study
-
CLINICAL_TRIALS study record update · 2023-06-01Oxytocin Treatment in Neonates and Infants Aged From 0 to 3 Months With Prader-Willi Syndrome : a Study of Safety and Efficacy on Oral and Social Skills and Feeding Behavior of Intranasal Administration of Oxytocin vs Placebo
-
CLINICAL_TRIALS study record update · 2023-04-18Profiling of the Gut Microbiome in Children With Prader-Willi Syndrome: a Fiber Intervention to Target Hyperphagia (AIM 2)
-
CLINICAL_TRIALS study record update · 2023-04-03Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory
-
CLINICAL_TRIALS study record update · 2023-02-16Growth Hormone Study in Adults With Prader-Willi Syndroom
-
CLINICAL_TRIALS study record update · 2022-12-13A Phase 2b, Double-blind, Randomized, Placebo-controlled, Multi-center, 16-week Dose Finding, Safety and Efficacy Study With Open-label Extension (OLE) Period of Tesomet in Subjects With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2022-10-06A Phase 3, Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2022-09-13Chronic Stress, Cognition, and Food Cue Reactivity in Prader-Willi Syndrome: A Magnetoencephalography Study
-
CLINICAL_TRIALS study record update · 2022-08-25Probiotics as a Long-term Treatment Strategy for Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2022-03-31Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell
-
CLINICAL_TRIALS study record update · 2022-03-07Evaluating the Effectiveness of Home-based SSP on Individuals With PWS
-
CLINICAL_TRIALS study record update · 2021-11-17Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
-
CLINICAL_TRIALS study record update · 2021-10-07Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2021-09-24Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
-
CLINICAL_TRIALS study record update · 2021-08-03An Open-Label Study of Diazoxide Choline Controlled-Release Tablet in Patients With Prader-Willi Syndrome